Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMETEST II: RA-RPLND for Stage II Seminoma
NCT06144736Phase 2Recruiting
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, etoposide, bleomycin in seminoma, sponsored by Heinrich Heine University Düsseldorf. Started Aug 2023; status: recruiting.
02
Drugs
cisplatinetoposidebleomycin
03
Conditions
seminoma
Beyond the preview
Go deeper on NCT06144736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144736.